Anti-Myeloid Specific Antigen antibody [BM-2]

Cat# NB-22-51819-100

Size : 100µg

Brand : Neo Biotech

Contact local distributor :


Phone : +1 850 650 7790

  • Anti-Myeloid Specific Antigen antibody [BM-2]

General Info

Host: Mouse
Applications: FC/IHC
Reactivity: Human/Macaque Monkey
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Mouse monoclonal antibody anti-Myeloid Specific antigen is suitable for use in Flow Cytometry and Immunohistochemistry research applications.
Clonality: Monoclonal
Clone ID: BM-2
Conjugation: Unconjugated
Isotype: IgG1
Formulation: PBS with 0.02% Sodium Azide.
Purification: Affinity purified from tissue culture.
Concentration: Can be provided as 100 µg/mL, 500 µg/mL or 1mg/mL.
Dilution Range: Flow cytometry (0.5-1.0 µg/million cells in 0.1 ml). Immunohistology (1-2 µg/ml for 30 min at RT; staining of formalin-fixed tissues better after boiling tissue sections in 10mM Citrate Buffer, pH6, 0, for 10-20 min followed by cooling at RT for 20 m
Storage Instruction: Store for up to 1 year at 2-8°C upon receipt.

Information

Immunogen: A BALB/c nuclei from Pokeweed mitogen stimulated human peripheral blood lymphocytes were used as immunogen.Fusion partner: NS-1.

Description

Background Until recently, immunological markers for myeloid cells have been lacking, especially those which identify different levels of cellular differentiation. The BM series provides a new panel of monoclonal antibodies which stain early precursor and mature forms of human myeloid cells. This panel of monoclonal antibodies reacts with antigenic determinants present in normal myeloid cells and leukemias of similar derivation. BM-2 recognizes a cytoplasmic antigen expressed in mature human granulocytes (polys) residing in lymphoid and non-lymphoid tissues. It does not react with any other cell type in human tissues.

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance